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Neurons of cranial sensory ganglia are derived from the neural crest and ectodermal placodes, but the mechanisms that control the relative
contributions of each are not understood. Crest cells of the second branchial arch generate few facial ganglion neurons and no vestibuloacoustic
ganglion neurons, but crest cells in other branchial arches generate many sensory neurons. Here we report that the facial ganglia of Hoxa2 mutant
mice contain a large population of crest-derived neurons, suggesting that Hoxa2 normally represses the neurogenic potential of second arch crest
cells. This may represent an anterior transformation of second arch neural crest cells toward a fate resembling that of first arch neural crest cells,
which normally do not express Hoxa2 or any other Hox gene. We additionally found that overexpressing Hoxa2 in cultures of P19 embryonal
carcinoma cells reduced the frequency of spontaneous neuronal differentiation, but only in the presence of cotransfected Pbx and Meis Hox
cofactors. Finally, expression of Hoxa2 and the cofactors in chick neural crest cells populating the trigeminal ganglion also reduced the frequency of
neurogenesis in the intact embryo. These data suggest an unanticipated role for Hox genes in controlling the neurogenic potential of at least some
cranial neural crest cells.
© 2007 Elsevier Inc. All rights reserved.Keywords: Hoxa2; Cranial ganglia; Lineage marking; Neural crest; Neurogenesis; Hox genes; P19 cells; Pbx; MeisIntroduction
The sensory neurons of cranial nerve ganglia are mosaic
populations that include neurons generated by ectodermal
placodes and by neural crest cells in successive stages (Ayer-
LeLievre and LeDouarin, 1982; d’Amico-Martel and Noden,
1983). There are large and reproducible variations in the relative
numbers and positions of placode-derived and crest-derived
neurons in specific cranial ganglia. Whereas the trigeminal
ganglion contains many crest-derived neurons, the vestibuloa-
coustic ganglion contains none and the facial ganglion contains
very few. Placode- and crest-derived neurons associated with
the glossopharyngeal and vagal nerves are physically segre-
gated into distal (petrosal and nodose) and proximal (jugular
and superior) ganglia. The mechanisms that lead to these
variations have not been identified.⁎ Corresponding author. Fax: +1 216 368 4650.
E-mail address: ogorman@case.edu (S. O’Gorman).
1 These authors made equal contributions to the manuscript.
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doi:10.1016/j.ydbio.2007.11.032Manipulations that remove placode-derived neurons have
shown that cranial neural crest cells generate additional neurons
when placode-derived neurons are missing (Fode et al., 1998;
Harrison et al., 1995). A similar regulation of neurogenic
potential has been observed between early- and late-migrating
populations of neural crest cells in zebrafish dorsal root ganglia
(Raible and Eisen, 1996), and between Neurogenin2- (Neurog2)
and Neurogenin1- (Neurog1) dependent neurons of mammalian
dorsal root ganglia (Ma et al., 1999). Cranial neural crest cells
that do not normally form neurons, such as those of the nodose
ganglion, can generate neurons upon transplantation to appro-
priate environments (Ayer-LeLievre and LeDouarin, 1982).
Such observations have led to the suggestion that the presence
of placode-derived neurons normally represses neurogenesis by
cranial neural crest cells (Ayer-LeLievre and LeDouarin, 1982).
Differences in the numbers of crest-derived neurons may,
additionally or alternatively, reflect differences in the develop-
mental potential of crest cells themselves. Many non-neuronal
fates of cranial neural crest cells are modulated by the activities
of Hox genes (Couly et al., 2002). A striking example is the
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from the fourth rhombomere (r4) of the hindbrain and form the
mesenchyme of the second branchial arch. Loss of Hoxa2
function results in neonatal lethality and the transformation of
some second arch skeletal elements toward fates normally
assumed by first arch neural crest cells (Gendron-Maguire et al.,
1993; Rijli et al., 1993). The phenotype is similar to that
observed after heterotopic transplantation of the neuroepithe-
lium that normally gives rise to first arch neural crest into sites
that give rise to second arch neural crest (Noden, 1983). Add-
itionally, ectopic expression of Hoxa2 in the first branchial arch
leads to alterations of crest cell fate that are consistent with a
loss of first arch identity (Creuzet et al., 2002; Grammatopoulos
et al., 2000). Hoxa2 thus appears to actively promote deve-
lopment of second arch skeletal elements and connective tissues
from crest-derived mesenchyme. WhetherHoxa2, or indeed any
Hox gene, contributes to the control of neurogenesis by neural
crest cells within developing cranial ganglia is not known.
In this study, we have used a lineage marking paradigm
based on the transient expression of a site-specific recombinase
(O’Gorman et al., 1991) to heritably label the second arch
neural crest cell lineage. As previously described by others
(Arenkiel et al., 2003), we found that in wild-type embryos the
neural crest population that arises from Hoxb1-expressing
progenitors in r4 preferentially formed glial cells in the facial
ganglion, but we also found that it formed a small number of
sensory neurons in the facial ganglion and all of the para-
sympathetic neurons of the ptergopalatine ganglion. Unexpect-
edly, we found that in mutant embryos lacking Hoxa2 function,
the r4-derived neural crest cells generated a large, super-
numerary population of facial ganglion neurons, suggesting that
Hoxa2 function normally represses neurogenesis in this
population of neural crest cells. This hypothesis was tested by
overexpressing Hoxa2 in high-density cultures of P19 embry-
onal carcinoma cells (Jones-Villeneuve et al., 1982; Rudniki
and McBurney, 1987). Coexpression of Hoxa2, along with Pbx
and Meis cofactors, reduced the probability of neuronal
differentiation in these experiments, an effect that could be
antagonized by simultaneous expression of a Hox3 paralogue.
Finally, in ovo electroporation was used to express Hoxa2 and
the cofactors in neural crest cells that enter the trigeminal
ganglion, which normally generate both neurons and glia. We
found that the frequency with which transfected cells differ-
entiated as neurons was significantly reduced. Collectively,
these data demonstrate that the commitment of pluripotent cells
to neuronal and non-neuronal fates may be influenced by the
activity of Hox genes and their cofactors.
Materials and methods
Mice
The Hoxb1 locus was isolated from a 129 strain genomic lambda phage
library (Stratagene) using a cDNA probe (Frohman et al., 1990). A targeting
vector (Fig. 1A) was prepared that contained a Cre recombinase coding
sequence from pOG231 (O’Gorman et al., 1997), a neomycin resistance cassette
from pMC1neo-polyA (Thomas and Capecchi, 1987), and a HSV thymidine
kinase cassette from pNT (Tybulewicz et al., 1991). Linearized vector wastransfected into CCE embryonic stem cells (Robertson et al., 1986) and
recombinant clones were isolated by selection with G418 and ganciclovir and
identified by Southern blotting (Fig. 1B). Germline transmission of two
independent clones was obtained; both recombinant alleles had phenotypes that
were the same as reported null alleles (Goddard et al., 1996; Studer et al., 1996)
and behaved as simple Mendelian recessives. The mutant alleles were
backcrossed onto a B6D2F1 background. Mice with a null allele of Hoxa2
(hoxa2tm1Grid; Gendron-Maguire et al., 1993) were obtained from Jackson
Laboratories. Mice bearing the Cre-conditional R26R reporter allele (Soriano,
1999) were obtained from Philippe Soriano. Mice bearing a null allele of the
Bdnf locus (Conover et al., 1995) were obtained from David Katz. Each strain
was maintained by backcrossing to B6D2F1 hybrids. For timed pregnancies, the
day of vaginal plugging was designated E0.5. Embryos were harvested into cold
PBS and fixed in 4% phosphate-buffered formaldehyde for 1–4 h, washed in
PBS, and either stored in methanol for whole mount in situ hybridization or
equilibrated with 30% sucrose in PBS for frozen sectioning for immunohis-
tochemistry or in situ hybridization.
Expression constructs
Expression plasmids for GFP (pUS2-GFP), Neurogenin1 (pCS2-Ngn1),
NeuroD2 (pUS2-NeuroD2) (McCormick et al., 1996), and puromycin (pUS2-
puro) were generously provided by Dr. David Turner. Expression plasmids for
Hoxa2 (pCMV-Hoxa2), Pbx1 (pCMV-Pbx1), and Meis1 (pCMV-Meis1) were
prepared by amplifying the respective coding sequences from a mouse cDNA
library (Clonetech) and cloning the products into pCDNA3.1 (Invitrogen). The
pCMV-Hoxd3 expression plasmid was generously provided by Nancy
Boudreau (Boudreau et al., 1997). pUS2-Neurog1 was made by shuttling the
I sequence from pCS2-Ngn1 into pUS2. A plasmid expressing a mutant Hoxa2
(W99A) protein unable to heterodimerize with Pbx proteins was prepared by
using a mutagenesis kit (Quikchange, Stratagene) to change the conserved
tryptophan residue of the pentapeptide sequence (Knoepfler and Kamps, 1995)
to alanine. The resulting plasmid was fully sequenced to confirm that only the
desired change occurred.
Neuronal differentiation assays using P19 cells
P19 cells were maintained at subconfluent densities in alpha MEM with
7.5% calf serum and 2.5% fetal bovine serum (FBS, Gibco) (Rudniki and
McBurney, 1987). Twenty-four hours before transfection, aliquots of 2×105
cells were plated in 6 cm dishes. In the first series of experiments, P19 cells were
transfected with pUS2-GFP and various combinations of expression plasmids
for Hoxa2, Hoxd3, Pbx1, Meis1, and Neurog1. Each transfection included 2 μg
of one to four expression plasmids, 2 μg of pUS2-GFP, and enough neutral
vector (pUS2-puro) to bring the total amount of plasmid DNA to 10 μg in
FuGene6 transfection reagent (Roche). After overnight incubation, cells were
resuspended and seeded on gelatin-coated cover-slips in 24-well plates (2×104
cells per well) and 24 h later the medium was changed to Opti-MEM with 1%
FBS to promote differentiation. The medium was changed after a further two
days and the cells were fixed and stained with antibodies to PGP9.5 (Wilkinson
et al., 1989) after a total of 4 days in differentiation medium. Given the low
frequencies of neuronal differentiation seen in most of these transfections,
neuronal differentiation was scored as the fraction of PGP9.5-positive neurons
that arose from transfected (GFP-positive) cells. Because neuronal differentia-
tion was efficiently induced by Neurog1, neurogenesis in transfections that
included the Neurog1 expression plasmid was scored as the fraction of GFP-
positive cells that were also PGP9.5 positive.
In a second series of experiments, a test population of P19 cells was seeded
onto feeder layers of P19 cells that had been transfected with a combination of
Hoxa2, Pbx1, and Meis1 expression plasmids (see timeline in Supplementary
Fig. 1). The feeder cells were transfected on day 1 as described above (omitting
the GFP expression plasmid), mitotically inactivated 24 h later using Mito-
mycinC, and then seeded at a density of 6×105 cells per well on gelatinized
coverslips in 24-well plates (day 2). The test population of P19 cells was
transfected with pUS2-GFP on day 2, and was resuspended and plated on the
feeder cells at a density of 3000 cells per well in Opti-MEMwith 1% FBS on day
3. The cultures were maintained with daily changes of medium for a further 4
days before being fixed and labeled for scoring. In these experiments, neuronal
Fig. 1. Structure and activity of B1Cre allele. (A) Vector (V), native Hoxb1 locus (N), and recombinant B1Cre allele (R). The targeting vector contained (5′ to 3′) an
HSV thymidine kinase cassette (tk), 1.8 kb of Hoxb1 genomic sequence, a Cre coding sequence (c), a neomycin cassette (n), and 10.5 kb of genomic sequence. Hoxb1
exons are shown as black rectangles, BamHI (b) endonuclease sites and the sizes (kb) of the fragments generated are indicated. (B) Southern blots of BamHI-digested
DNA from wild-type (cce) embryonic stem cells and three recombinant clones (54, 56, 89) probed with an external probe (hatched box in panel A). Other digestions
and probes confirmed the organization of the recombinant clones (not shown). (C) Histochemical staining of +/B1Cre, +/R26R (Hoxa2 +/+) embryo at E8.5 showed
marker expression in the presumptive r4 domain (arrow). (D, E) Staining of E9.5 +/B1Cre (D) and B1Cre/B1Cre (E) embryos (also +/R26R, Hoxa2 +/+) showing marker
expression in r4 and the second branchial arch (b2) and the absence of product in the first arch (b1). B1Cre/B1Cre embryos showed increased labeling of posterior
hindbrain and third arch. (F–I) Horizontal sections (anterior to the top, midline to the right) of an E9.5 +/B1Cre, +/R26R (Hoxa2 +/+) embryo. (F, H) Adjacent sections
showing Hoxb1 (F) and Cre (H) expression in r4, lack of expression in r3 and r5, and sharply reduced expression in r4-derived neural crest cells (nc) (iv, fourth
ventricle). (G, I) Sustained marker expression in the neural crest in the sections shown in F and H, respectively. (J) Sagittal section (dorsal to right and anterior at top) of
an E10.5 Hoxa2 +/+, +/B1Cre, and +/R26R embryo showing labeling of second arch mesenchyme, including cells dorsal to the pharyngeal cavity (*), lack of first arch
labeling, and low level of labeling in the third arch (b3). (ct: chorda tympani, gp: greater petrosal nerve) Scale bars: I, 50 μm for panels panels F–I; J, 100 μm.
173X. Yang et al. / Developmental Biology 314 (2008) 171–188differentiation was scored as the fraction of GFP-positive cells that had
differentiated as neurons (PGP9.5-positive).
In ovo electroporation
In ovo electroporations were done on HH stage 10 (Hamburger and Hamil-
ton, 1952) chick embryos. Expression plasmids were mixed in PBS containing
Trypan blue and pressure-injected into the lumen of the neural tube just posterior
to the midbrain vesicles. All injection mixes contained 4 μg/μl of a CMV-GFP
expression plasmid, various combinations of Hoxa2, Pbx1, and Meis1
expression plasmids (each at 1.5 μg/μl), and enough empty CMV expression
vector to bring the total plasmid concentration to 8.5 μg/μl for each mix.
Electroporation was performed using an BTX electroporator (ECM 830)delivering five 50 ms square pulses of 18 V through platinum electrodes placed
on either side of the neural tube at the midbrain level. Transfected embryos were
allowed to develop for 4 days and then examined under fluorescent illumination
using a Zeiss dissecting microscope. Embryos expressing GFP in trigeminal
ganglia were fixed and processed for immunohistochemistry.
Immunohistochemistry
Sections or coverslips were blocked with 5% normal donkey serum in PBST
(PBS plus 0.3% triton) and primary antibodies were applied overnight at 4 °C.
Primary antibodies included goat anti b-galactosidase (Biogenesis, 1:3000);
rabbit anti b-galactosidase (Cappel, 1:5000); mouse anti b-tubulin (Tuj1)
(Babco, 1:1000) (Lee et al., 1990); rabbit anti neurofilament 200 (Sigma,
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mouse anti-Islet1/2 (Developmental Studies Hybridoma Bank, 1:100) (Ericson
et al., 1992); rabbit anti TrkA (Chemicon, 1:500); rabbit anti phosphohistone H3
(Upstate, 1:800); and mouse anti Sox10 (Lo et al., 2002). Secondary antibodies
(Jackson Immunochemicals) conjugated to either Cy3 or FITC were applied for
2 h. Histological material generated from mouse embryos was examined and
photographed with a Zeiss Axioskop microscope equipped with a Hamamatsu
digital camera, while sections of electroporated chick embryos were
photographed using a Zeiss LSM410 confocal microscope.
In situ hybridization
The probes for mouse Delta-like1 (Dll1; Bettenhausen et al., 1995), mouse
Delta-like3 (Dll3; Dunwoodie et al., 1997), and Notch1 (Conlon et al., 1995)
were provided by Ronald Conlon. The second exon of Hoxa2 and the entire
Neurog1 and Neurogenin2 (Neurog2) coding sequences were amplified by
PCR from genomic DNA, cloned into pCR4-TOPO (Invitrogen), and their
identities were confirmed by sequencing. Digoxigenin-labeled sense and anti-
sense probes were synthesized using a kit (Roche) according to the manu-
facturer’s instructions. Hybridization was performed as described by Schaeren-
Wiemers and Gerfin-Moser (1993).
Quantification
For sectioned material, cell counts were made on every fourth, 15 μ thick
frozen section from serial sets through the facial and vestibuloacoustic ganglia of
E14.5 embryos. Singly PGP9.5-positive cellular profiles and doubly PGP9.5-
and β-galactosidase marker-positive profiles were counted separately without
correction for nuclear size. The volumes of ganglia were determined using
Openlab software. The data presented represent counts from both ganglia of
three wild-type and three mutant embryos that were then averaged. For the first
series of P19 cell transfections, coverslips were scanned in a predetermined,
orthogonal pattern. All fields containing PGP9.5-positive neuronal profiles were
photographed until at least 200 cells had been sampled, and the number of
PGP9.5-positive cells that coexpressed GFP was determined. For the feeder cell
experiment and the Neurog1 transfections, coverslips were scanned in the same
manner, all fields containing GFP-positive cells were photographed until a total
of 200 cells had been sampled, and the number of GFP-positive cells that
coexpressed PGP9.5 was determined. All transfection assays were repeated
three times. For quantification of neurogenesis in chick embryos, approximately
100 GFP-positive cells were scored for nuclear Islet1/2 expression in at least
three embryos for each plasmid combination.Results
Labeling of r4 and r4-derived neural crest by the B1Cre allele
To mark the neural crest that populates the second branchial
arch for lineage analysis, we prepared a recombinant allele of
Hoxb1 (B1Cre) in which the first exon was replaced by the
coding sequence for Cre recombinase (Materials and methods,
Figs. 1A, B). This allele was null for Hoxb1 expression (not
shown) and was predicted to express Cre in tissues that
normally express Hoxb1. Cre-mediated recombination of a
Cre-conditional reporter allele would be expected to heritably
label the lineages that descend from Hoxb1-expressing pro-
genitors. The expression pattern of Hoxb1 is highly dynamic
(Frohman et al., 1990; Murphy et al., 1989). At early stages
(embryonic day 7.5 (E7.5)), it is expressed in the posterior
primitive streak and flanking mesoderm. By E8.5, expression
is observed in the neural tube up to the presumptive r3/4
boundary in the hindbrain, and is elevated in r4 itself. Bet-
ween E8.5 and E9.5, Hoxb1 expression is increases in r4 butrapidly decreases in more caudal regions of the hindbrain.
Based on this expression pattern, the B1Cre allele could
potentially label all cells derived from rhombomere 4, including
the r4-derived neural crest cells that enter the second branchial
arch.
In +/B1Cre embryos, the patterns of Hoxb1 protein expres-
sion (from the wild-type allele) and Cre recombinase expression
(from the B1Cre allele) were identical (Figs. 1F, H, and data not
shown). At E9.5, cells in r4 expressed high levels of both
proteins. By contrast, both Hoxb1 and Cre proteins were nearly
undetectable in neural crest cells that had emerged from r4. This
finding is consistent with reports that Hoxb1 mRNA is not
expressed in r4-derived neural crest (Frohman et al., 1990;
Murphy and Hill, 1991). We were unable to detect Hoxb1 or
Cre protein in more distal cells of the second branchial arch at
E9.5 or E10.5, or in any craniofacial tissues or the hindbrain at
E11.5, E12.5, E15.5, or P0 (not shown). We never observed
either Hoxb1 or Cre expression in the neural tube rostral to r4.
In embryos containing the B1Cre allele and the Cre-
conditional R26R β-galactosidase marker allele (Soriano,
1999) (+/B1Cre; +/R26R), β-galactosidase expression from the
recombined marker allele could be observed in the presumptive
r4 territory as early as E8.75 (Fig. 1C). By E9.5, all cells in r4
expressed the marker (Figs. 1D, G, I). By contrast, no marker
expression was observed in neural tissues anterior to r4, and
only low levels of marker activation were seen in more posterior
rhombomeres. The labeling of the posterior hindbrain is likely
to result from the transient expression of Hoxb1 and Cre prior to
approximately E9. Considerably more recombination in r5 and
the posterior hindbrain was seen in embryos homozygous for
the B1Cre allele (Fig. 1E). In these embryos, r4 was still com-
pletely labeled, despite the fact that Hoxb1 positively regulates
its own expression (Popperl et al., 1995).
At E10.5, the territory expressing the marker extended from
the root of the facial nerve to the distal extremity of the second
branchial arch and included virtually all second arch mesench-
ymal cells (Figs. 1J, 2A). Temporally, neural crest cells populate
the branchial arches in a distal to proximal order, suggesting that
the marker was recombined in the first neural crest cells to
emerge from r4. The central mesodermal core, which could be
identified by the expression of either MyoD (not shown) or
Islet1/2 proteins (Fig. 2A), did not express the marker. The
surface ectoderm, including the neurogenic ectodermal placode,
was also negative for marker expression (Fig. 2B). Unlabeled,
Islet1/2-positive cells were positioned between the placode and
the developing facial ganglion; these were likely to be neuro-
blasts that had recently delaminated from the placode that were
migrating toward the ganglion (Fig. 2B).
In summary, Cre expression from the B1Cre allele led to
recombination of the R26R allele and β-galactosidase expres-
sion in all cells of r4 by E9.5, and resulted in marker expression
by the r4-derived neural crest cell lineage, including at least
most of the earliest r4-derived crest to emerge from the
hindbrain. Our immunohistochemical data confirmed observa-
tions made by others using in situ hybridization that suggest that
Hoxb1 expression is extinguished in craniofacial tissues after
approximately E10.5. We have additionally been unable to
Fig. 2. Marking of second arch tissues by the B1Cre allele in +/B1Cre, +/R26R (Hoxa2 +/+) embryos. (A) Sagittal section (dorsal at top and anterior to left) through r4,
the facial nerve (nvii) and facial (gvii) and vestibuloacoustic (gviii) ganglia, and the first and second branchial arch (b1, b2) of an E10.5 embryo labeled with antibodies
to β-galactosidase (red) and Islet1/2 proteins (green). The mesoderm (mes) and neurons of the ganglia were Islet1/2 positive and marker negative and the ectodermal
placode (pl) was faintly positive for Islet proteins. The arrow indicates a cluster of neurons that expressed β-galactosidase. (B) Islet1/2 positive cells (arrow) located
between the placode and facial ganglion. (C) Sagittal section of an E10.5 embryo labeled with antibodies to Sox10 (green) and β-galactosidase (red). The early
outgrowth of the greater petrosal (ngp) and chorda tympani (nct) nerves included cells that expressed the marker and Sox10. Dotted line outlines pharyngeal cavity.
The signals for each antibody in the chorda tympani are shown separately in panels D and E. (F) Earliest outgrowth of chorda tympani in another E10.5 embryo showed
isolated axons (arrowheads) labeled with β-tubulin antibody (Tuj1, green). (G) Horizontal section of an E11.5 embryo through the chorda tympani and motor root
(mvii) of the facial nerve labeled with antibodies to β-tubulin (green) and β-galactosidase (red). Inset shows an anterior portion of the chorda tympani within the first
arch associated with marker-positive cells. (H–K) DAPI stain of cell nuclei (H, J) and immunostaining of β-galactosidase expression (I, K) within the boxes outlined in
panel G showing that cells were largely excluded from the axon fascicles of the chorda tympani (H) and motor root (*, J), that the axons of the chorda tympani did not
express the marker (I), and that axons of the motor root (*, K) did express the marker. (L) Sagittal section of E14.5 embryo showing that three principal branches of the
facial nerve extended from the second arch into the first arch and were accompanied by labeled cells. Arrow indicates axons of a trigeminal nerve branch not associated
with labeled cells (nvii, mixed trunk of facial nerve). (M) Histochemical staining of the roof of the oral cavity at E14.5 showing marker expression in the ptergopalatine
ganglion (g) and greater petrosal nerve. (N) Sagittal section through the ptergopalatine ganglion of an E13.5 embryo labeled with antibodies to β-galactosidase (red)
and PGP9.5 (green) to show double labeling of neurons and marker only labeling of peripheral glial cells. Arrowhead points to trigeminal axons not associated with
second arch glial cells. (O) Sensory axons (*) passing from the vestibuloacoustic ganglion to the otic vesicle (ov) were associated with cells that expressed the lineage
marker. Inset shows the marker signal alone. Scale bars: A–C, G, 100 μm; L, 200 μm; N, O, 50 μm.
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have not observed novel sites of marker expression that cannot
be easily traced to the migration of second arch cells in a staged
embryo series. We conclude that virtually all of the cells within
the second branchial arch territory that express the R26R marker
in +/B1Cre; +/R26R embryos arise from r4-derived neural crest
cells, and that populations that do not express the marker do not
arise from r4-derived crest cells.
Labeling of anterior facial nerve branches
The boundary between the mesenchyme of the first and
second branchial arches was sharply defined, and through E15
the only marker-expressing cells consistently found anterior to
this boundary were associated with branches of the facial nerve
(Figs. 2C–O). The greater petrosal nerve branches from the
facial nerve trunk immediately distal to the facial ganglion, runs
anteriorly above the oropharynx to innervate the ptergopalatine
ganglion, and is comprised of preganglionic parasympathetic
axons. At E10.5, axons of the nerve had emerged from the
second arch territory and were invested with cells that expressed
the marker; some of these also expressed Sox10, which labels
glial lineages (Kuhlbrodt et al., 1998) (Fig. 2C). At E13.5, the
ptergopalatine ganglion was populated by neuronal and non-
neuronal cells that expressed the second arch lineage marker
(Figs. 2M, N).
A second division of the facial nerve is the chorda tympani,
which branches from the facial nerve trunk ventral to the first
pharyngeal pouch and contains sensory axons of facial ganglion
neurons that innervate lingual taste buds. In some E10.5
specimens, the initial axons of the chorda tympani were
observed to cross into first arch mesenchyme without being
accompanied by second arch cells (Fig. 2F), but in most E10.5
specimens and at all later stages the nerve was already invested
with Sox10-positive cells that coexpressed the marker (Figs.
2C–E, G (inset), L). The axons of the chorda tympani, like their
parental cell bodies (see below), did not express the lineage
marker (Figs. 2G–I). By contrast, axons of the third major facial
nerve branch, its motor root, did express the marker (Figs. 2G, J,
K). The motor root exited the second arch territory between
E11.5 and E12.5 and was also accompanied by many marker
positive second arch cells (Fig. 2L). Labeled second arch cells
were also associated with the distal sensory axons of the eighth
cranial nerve (Fig. 2O).
r4 neural crest generates few neurons in the facial ganglion of
wild-type embryos
At E10.5, only a few of the Islet1/2-positive sensory neurons
of the facial ganglia in wild-type embryos expressed the lineage
marker (Fig. 3A). Because the ectodermal placode of the second
arch did not express the lineage marker while virtually all r4-
derived neural crest cells did, and because the placode con-
tributes neurons to the facial ganglion in both birds (Ayer-
LeLievre and LeDouarin, 1982; d’Amico-Martel and Noden,
1983) and mice (Fode et al., 1998), we refer to these marker-
negative sensory neurons as placodal neurons. Cells expressingthe lineage marker and Sox10, a marker of glial precursors
(Kuhlbrodt et al., 1998) were scattered throughout the ganglion
and ensheathed its external margins (Fig. 3B). At all stages
examined (E10.5–E17.5), small clusters of neurons that
expressed the lineage marker were consistently found in the
proximal ganglion near or within the facial nerve root, and
additional labeled neurons were scattered at the periphery of the
ganglion (Figs. 3A, C). At E14.5, approximately 6% of facial
ganglion neurons expressed the lineage marker (Table 1). The
fraction of crest-derived neurons did not appear changed at
E17.5 (not shown).
Neural crest-derived neurons in the facial ganglia of Hoxa2
mutant mice
Embryos heterozygous for the B1Cre allele and either hete-
rozygous or homozygous for the hoxa2tm1Grid null allele did not
show changes in the expression of Hoxb1 or Cre at E9.5, when
the expression of both in the hindbrain was confined to r4 (not
shown). As in wild-type embryos, only faint immunoreactivity
for Hoxb1 protein was observed in the ventral portion of r4 at
E10.5, and none could be detected in hindbrain or craniofacial
tissues at E11.5 or E12.5. This is consistent with previous
reports that the expression of the Hoxb1 allele is not altered in
mice lacking Hoxa2 function (Gendron-Maguire et al., 1993;
Rijli et al., 1993; Davenne et al., 1999).
At E10.5, the distribution of placode and crest-derived cells
within the facial ganglia of embryos homozygous for the
hoxa2tm1Grid null allele was similar to that in controls. In both,
the majority of Islet1/2-expressing neurons did not express the
lineage marker (Figs. 3A, D), and both contained small numbers
of marker positive neurons in proximal portions of the ganglion
(arrows). By contrast, most Sox10-positive presumptive glial
cells did express the marker (Figs. 3B, E), although a few
marker-negative glial cells were present in both mutant and
wild-type embryos (arrowheads). A consistent and striking
difference arose by E11.5, when a substantial number of
neurons expressing the lineage marker were present in the
proximal ganglion of the mutants (Figs. 3C, F). By E14.5,
placode- and crest-derived neurons formed abutting, largely
distinct portions of the ganglion (Fig. 3G), and the number of
crest-derived neurons in Hoxa2 mutant embryos exceeded the
total number of neurons present in wild-type embryos (Table 1).
The emergence of the crest-derived population was not caused
by a marked deficiency of placode-derived neurons, which were
present in similar numbers in wild-type and mutant embryos
(Table 1). Phosphohistone H3 and Islet1/2 labeling showed
comparable numbers of mitotically active neuroblasts in E10.5
control and mutant embryos (Figs. 4A, B). Because there was a
slight reduction in the number of placode-derived neurons in the
sample of Hoxa2 mutant embryos, and because the complete
absence of placode-derived neurons in the facial ganglion has
been associated with the delayed generation of sensory neurons,
presumably by neural crest, in Neurog2 mutant embryos (Fode
et al., 1998), we asked if reductions of facial ganglion cell
number necessarily invoke the production of crest-derived neu-
rons. We therefore combined the B1Cre and R26R alleles with a
Fig. 3. Facial ganglia of wild-type and Hoxa2 mutant embryos. β-galactosidase is shown in red in all panels, colabeling with other markers is shown in green. (A–F)
Sagittal sections of E10.5 (A, B, D, E) and E11.5 (C, F) wild-type (A–C) and Hoxa2mutant (D–F) embryos. (A, D) Islet1/2 colabeling shows the similar organization
of facial ganglia in wild-type and mutant embryos at E10.5, both of which contained small numbers of crest-derived neurons in the proximal portion of the ganglion
(arrows). (B, E) Sox10 labeling shows that most cells in the glial lineage coexpressed the lineage marker in both mutant and wild-type embryos, although a few cells in
each did not (e.g., arrowheads). (C, F) At E11.5, Islet1/2 colabeling shows a few doubly labeled neurons in a wild-type ganglion (arrows, C) and a substantial
population of crest-derived neurons (gviinc, F) in the mutant. (G) PGP9.5 colabeling at E14.5 shows a large population of crest-derived neurons (gviinc) in a Hoxa2
mutant embryo that express both Islet1/2 and the lineage marker: this population was not present in wild-type embryos (see Figs. 4C, D). (H) PGP9.5 colabeling of the
facial ganglion of an E14.5 BDNF mutant embryo showed that the neural crest formed few neurons. Scale bars: 50 μm.
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though the number of facial ganglion neurons in embryos
without Bdnf function is reduced by approximately 60% (Jones
et al., 1994), examination of serial sections from two BdnfTable 1
Neuronal number in the facial ganglion of wild-type and Hoxa2 and Hoxb1
mutant mice
Genotype A2+/+:B1Cre+/− A2−/−:B1Cre+/− A2+/+:B1Cre−/−
Mean±S.E. % Mean±S.E. % Mean±S.E %
Total 991±59
(n=5)
100 3622±253**
(n=6)
365 1232±53*
(n=6)
124
Placode 933±56
(n=5)
100 828±78NS
(n=6)
89 1144±48*
(n=6)
122
Crest 58±11
(n=5)
100 2803±228**
(n=6)
4832 90±11NS
(n=6)
155
Counts of total neurons, neurons that did not express the lineage marker
(placode), and neurons that did express the lineage marker (crest) in the facial
ganglia of E14.5 embryos. %, percent of A2+/+; B1Cre+/− value; n, number of
ganglia counted; NS: no significant difference from A2+/+; B1Cre+/− by
unpaired Student's t-test; *, 0.01bpb0.05; **, pb0.0001.mutant embryos revealed no evidence of supernumerary, crest-
derived neurons at E14.5 (Fig. 3H).
Supernumerary, crest-derived neurons express TrkA receptors
The survival of cranial sensory neurons requires the activities
of neurotrophins and Trk receptors (Huang and Reichardt,
2001; Huang and Reichardt, 2003). Most facial ganglion
neurons require either BDNF or NT3 for survival (Liu and
Jaenisch, 2000), and express either TrkB or TrkC, while a small
number express TrkA (Matsumoto et al., 2001). When the facial
ganglia of Hoxa2 mutant embryos were examined by
immunohistochemistry at E12.5 and E14.5, the crest-derived
neurons were found to express TrkA, whereas few neurons in
the distal ganglion of mutant embryos or the entire facial
ganglion of wild-type embryos expressed this receptor (Figs.
4C, D). TrkA positive processes were observed to extend
distally into the facial nerve and proximally into the CNS in the
mutants. Whether these TrkA-positive processes establish
functional connections was not determined.
Fig. 4. Neuronal proliferation and TrkA expression in facial ganglia. (A, B) Facial (gvii) and vestibuloacoustic (gviii) ganglia of E10.5 wild-type (A) and Hoxa2
mutant (B) embryos labeled with antibodies to Islet1/2 (red) to label neurons and phosphohistone H3 (green) to label dividing cells. Arrows indicate doubly labeled
cells shown in insets. (C, D) Trigeminal (gv), facial, and vestibuloacoustic ganglia of wild-type (C) and mutant (D) E14.5 embryos labeled with antibodies to the
lineage marker (red) and TrkA (green). The facial ganglia of wild-type embryos contained few TrkA-positive neurons, while the trigeminal ganglia contained many.
Inset in panel C shows a section of the facial ganglion from another embryo that contains two placode-derived neurons (arrowheads) and one crest-derived neuron
(arrow) that expressed TrkA. Most neurons of the crest-derived portion of the facial ganglion in mutant embryos expressed TrkA (D) and TrkA-positive axons exited
the ganglion (arrowhead, inset). Scale bars: 50 μm.
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In principle, a reduction of Hoxb1 expression caused by the
B1Cre null allele could have altered ganglionic lineages in
control andHoxa2mutant embryos. Two lines of data suggested
this was not the case. Examination of TrkA expression inHoxa2
mutant embryos that were wild-type at the Hoxb1 locus showed
that at both E12.5 and E14.5 the same supernumerary population
of TrkA-expressing neurons was present (not shown). We also
determined the numbers and distributions of labeled and
unlabeled neurons in embryos that were homozygous for the
B1Cre allele and wild-type at the Hoxa2 locus. As in +/B1cre
embryos, B1Cre/B1Cre embryos showed uniform labeling of the
r4-derived neural crest population (Fig. 1E and data not shown).
At E14.5, the numbers of crest-derived neurons in +/B1Cre and
B1Cre/B1Cre embryos were similar, and the number of unlabeled,
placode-derived neurons was, if anything, slightly increased in
B1Cre/B1Cre embryos (Table 1). It is therefore unlikely that
haploinsufficiency for Hoxb1 function contributed to the
phenotype we have ascribed to the loss of Hoxa2 function.
Expression of Hoxa2 in the facial ganglion and surrounding
tissues
To determine the potential sites of Hoxa2 gene action, we
examined its expression at E9.5 and at E11.5. At E9.5, Hoxa2
was expressed in the hindbrain, the facial nerve root, and in
second branchial arch mesenchyme, but not in the central,
neuron-rich portions of the facial and vestibuloacoustic ganglia
(Fig. 5A). A layer of non-neuronal cells surrounding the
ganglion expressed Hoxa2; those surrounding the vestibuloa-
coustic ganglion did not. We found no evidence of Hoxa2
expression in the ectodermal placode of the second branchialarch (not shown). Expression was observed in the posterior
ectoderm of the arch, as has been reported for the chick (Couly
et al., 1998). By E11.5, after many crest-derived neurons were
generated in Hoxa2mutants, expression in the nerve root and in
cells surrounding the facial ganglion had diminished (Fig. 5B).
Expression increased in the second arch mesenchyme, and low
levels were detected in third arch mesenchyme. Thus, the
placode-derived neurons of the facial ganglion, their ectodermal
precursors, and the mesenchyme surrounding the facial nerve
root and ganglion, did not express detectable levels of Hoxa2
mRNA from E9.5 to E11.5.
Ectopic gene activation in Hoxa2 mutant embryos
Because the generation of placode- and crest-derived neu-
rons in cranial ganglia is governed by multiple molecular path-
ways, we sought to determine if some of these were altered by
loss of Hoxa2 function. Neurog1 and Neurog2 are basic helix–
loop–helix proteins required for the development of different
populations of placode- and crest-derived neurons (Fode et al.,
1998; Ma et al., 1998, 1999). Neurog2 is required for the
generation of placode-derived facial ganglion neurons (Fode
et al., 1998). We found that Neurog2 was expressed by the
second arch placode of Hoxa2 mutant embryos at levels com-
parable to controls (Figs. 5C, D). Neurog1 is not required for
the generation of most facial ganglion neurons, but is essential
for the generation of many neural crest-derived neuronal popu-
lations (Ma et al., 1998, 1999). Neurog1 expression could not
be detected in the facial ganglia of E11.5 control embryos (Fig.
5E). By contrast, Neurog1 was strongly expressed in the ante-
rodorsal region of the facial ganglia of Hoxa2 mutant embryos
(Fig. 5F) surrounding and proximal to neuronal cell bodies (Fig.
5G). This corresponds to the position of marker-expressing
Fig. 5. Expression of molecular markers in wild-type andHoxa2mutant embryos. (A) Horizontal section (anterior to the top andmidline to the left) of an E9.5 wild-type
embryo labeled with aHoxa2 probe. Strong expression was seen in hindbrain rhombomeres 4 and 5 (r4, r5), in the neural crest of the seventh cranial nerve root (nc), and
weaker expression was seen in the mesenchyme of the second branchial arch (b2). Expression was not observed in the facial ganglion (gvii). (hv, head vein; gviii,
vestibuloacoustic ganglion; ov, otic vesicle). (B) Sagittal section (anterior to the left and dorsal to the top) of an E11.5 embryo. The hindbrain (hb) andmesenchyme of the
second branchial arch expressed high levels ofHoxa2, and low level expression was seen in rootlets of the seventh and eighth nerves (arrows) and in the mesenchyme of
the third branchial arch (b3). Expression in the seventh and eighth ganglia was similar to the background signal observed in the trigeminal ganglion (gv). (C, D)Neurog2
expression in E9.5 wild-type (C) and Hoxa2 mutant (D) embryos. The placode for the facial ganglion (F) of the mutant embryo showed apparently normal levels of
expression (T, P, N; trigeminal, petrosal, nodose placodes). (E–G)Neurog1 expression in sagittal sections of E11.5 wild-type (E) andmutant (F, G) embryos. Expression
was not seen in the region of the facial ganglion (*, E) in the wild-type embryo, but was seen in cells of the trigeminal ganglion (gv) and in neuronsmigrating from the otic
vesicle (arrowheads) of both. In the mutant embryo, high levels of Neurog1 were seen in the anterodorsal region of the facial ganglion (*, F). In panel G, Islet1/2
colabeling (green) shows that some of the cells in the region of high Neurog1 expression (*) were neurons. Scale bars: A, B, E, F, 100 μm; G, 50 μm.
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neurons at E12.5 (Fig. 4D and data not shown). Thus, the
expression of Neurog1, an early component of a neurogenic
molecular cascade, was inappropriately activated in the facial
ganglia of Hoxa2 mutants.
Members of the Notch/Delta family of receptors and ligands
may regulate neurogenesis and gliogenesis in developing senso-
ry ganglia (Lindsell et al., 1996; Myat et al., 1996; Wakamatsu
et al., 2000), although their roles in controlling neurogenesis in
cranial ganglia are not established. We were unable to detect
Dll1 transcripts in the facial ganglia of wild-type embryos at
E11.5 (Fig. 6A), and Notch1 expression was marginally higher
than background in the central portion of the facial ganglia and
elevated at its periphery (Fig. 6C). By contrast, the expression
of Dll1 and Notch1 was markedly elevated in the facial gangliaof E11.5 Hoxa2 mutant embryos (Figs. 6B, D). The highest
expression for both genes surrounded the more proximal por-
tions of the ganglion (Fig. 6E and data not shown). The expres-
sion of Notch1, Dll1, and Neurog1 in the facial ganglia of
mutant embryos was thus clearly different from that observed in
controls, and more closely resembled the expression pattern
observed in the trigeminal ganglia of control embryos.
Hoxa2, Pbx1, and Meis1 collectively inhibited spontaneous
neuronal differentiation of P19 cells
To test the idea that Hox gene function influences neuro-
genesis by cell populations capable of adopting both neural and
non-neural phenotypes, we overexpressed combinations of Hox
proteins and Pbx and Meis transcriptional cofactors in high
Fig. 6. Notch1 and Dll1 expression in wild-type and Hoxa2 mutant embryos. (A–F) Sagittal sections through the facial ganglia of E11.5 wild-type (A, C, E) and
mutant (B, D, F) embryos labeled with probes for Dll1 (A, B) and Notch1 (C, D). Panels E and F show the distribution of Islet 1/2 immunoreactivity in the sections
shown in panels C and D. Anterior is to the left and dorsal is up in all panels. Dll1 expression was not observed in the facial ganglia (gvii) of wild-type embryos, and
Notch1 expression was observed only at the periphery of the ganglion, but the expression of both was elevated in the facial ganglia of mutant embryos. Overlap of
Notch1 and Islet1/2 expression in anterodorsal portion of the facial ganglion in the mutant is indicated by arrows in panels D and F. The asterisks in panels C and D
indicate expression in cells migrating from the otic vesicle to the vestibuloacoustic ganglion. gv, trigeminal ganglion; gvii, facial ganglion; gviii, vestibuloacoustic
ganglion; hb, hindbrain; ov, otic vesicle. Scale bar: F, 200 μm for all panels.
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form a variety of differentiated cell types, and neurogenesis is
efficiently induced by aggregation culture in the presence of
retinoic acid (Jones-Villeneuve et al., 1982). Low levels of
neurogenesis are also seen in the absence of exogenous retinoic
acid in long-term cultures or culture under serum-free condi-
tions (Rudniki and McBurney, 1987). Because retinoic acid
exposure induces Hox gene expression in embryonal carcinoma
cell lines (Featherstone et al., 1988; Popperl and Featherstone,
1993; Simeone et al., 1990) and the expression of Pbx and Meis
proteins in P19 cells (Knoepfler and Kamps, 1997), we exam-
ined the effect of transfected Hoxa2, Pbx1, and Meis1 on neu-
ronal differentiation in high-density cultures of P19 cells main-
tained in low-serum medium.
Under the conditions used, transfection efficiencies were
uniformly high (ca. 50%) and the frequency of neuronal differ-
entiation was quite low (b5%) (Figs. 7A–C). We therefore
determined the fraction of PGP9.5-positive neurons (Wilkinsonet al., 1989) that arose from GFP-positive, transfected cells. We
found that when cells were transfected with GFP alone, approx-
imately 44% of the neurons arose from transfected cells (Fig.
7D). In cultures simultaneously transfected with Hoxa2, Pbx1,
and Meis1, there was a consistent reduction in the number of
neurons that arose from transfected cells, to approximately 32%
(pb0.05, unpaired t-test). The frequency of neurogenesis in
cultures transfected with Hoxa2 by itself, or with Hoxa2 and
either Pbx1 or Meis1, was similar to that observed in the GFP
control transfections (Fig. 7D and data not shown).
To ask whether the combined activity of Hoxa2 and Pbx1 in
these experiments required direct interactions between the pro-
teins, we used a mutation of Hoxa2 that prevents heterodimer
formation. Wild-type Hoxa2 contains a pentapeptide sequence
(consensus Y/F P W M K/R) amino-terminal to the home-
odomain that is required for cooperative DNA binding by Hox
and Pbx protein dimers (Knoepfler and Kamps, 1995), and
changing the tryptophan residue of this sequence prevents the
Fig. 7. Neuronal differentiation of P19 cells overexpressing Hox and cofactor proteins 4 days after transfection. (A–C) Immunofluorescence micrographs of a single
field showing (A) all transfected cells (GFP, green), (B) cells that have differentiated as neurons (PGP9.5, red), and (C) a merged image. Yellow cells in panel C are
transfected cells that differentiated as neurons. Arrowheads in panels A and C indicate transfected cells that did not become neurons, and arrows in panels B and C
indicate neurons that differentiated from untransfected cells. Scale bar in panel A indicates 50 μm for panels A–C. (D) Quantification of three independent experiments
showing the percentage of neurons (PGP9.5 positive cells) derived from cells transfected with expression plasmids for different combinations of Hox and Hox cofactor
proteins (*pb0.05 compared to GFP alone, **pb0.01 compared to GFP alone or Hoxa2/Pbx1/Meis1). (E) Quantification of three separate experiments using wild-
type or mutant Hoxa2 (W99A) (**pb0.01 compared to control or Hoxa2 (W99A) transfection).
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therefore prepared a mutant Hoxa2 expression construct
encoding a W99A mutation of the pentapeptide and performed
a second set of assays in P19 cells. Cotransfection of the W99A
Hoxa2 mutant together with Pbx1 and Meis1 did not alter the
base-line level of neuronal differentiation observed in control,
GFP-only transfections (Fig. 7E).
We also sought to determine if the inhibition of neurogenesis
represented a cell autonomous activity of Hoxa2, or if its
expression by surrounding cells could inhibit neurogenesis. We
therefore prepared a “test” population of GFP-expressing P19
cells and seeded them at low densities on high density “feeder”
layers of P19 cells that had been cotransfected with expression
plasmids for Hoxa2 and the cofactors, or with a control plasmid.
There was no difference in the frequency of neuronal differ-
entiation of test cells seeded on either type of feeder layer
(Supplementary Fig. 1). This result suggests that the Hoxa2-
mediated inhibition of neurogenesis we observed represented a
cell autonomous activity of Hoxa2.
Because we observed ectopic Neurog1 expression in the
facial ganglia of Hoxa2 mutant embryos (Figs. 5E–G), we at-
tempted to determine if Hoxa2 expression could alter neuro-
genesis caused by the forced expression of Neurog1 in P19
cells. As reported by others [Farah, 2000 #2316], we found that
a high proportion (89%) of P19 cells transfected with a Us2-Neurog1 expression vector differentiated as neurons (Supple-
mentary Fig. 2). This frequency was not altered by simultaneous
expression of Hoxa2, Pbx1, and Meis1.Thus, while the analysis
of Hoxa2 mutant mouse embryos suggests that Hoxa2 may
repress, directly or indirectly, the expression of Neurog1 from
the endogenous locus in vivo, these experiments suggest that
the neurogenesis initiated by high levels of Neurog1 is not
affected by Hoxa2.
Hoxd3 cotransfection relieved Hoxa2-mediated inhibition of
neuronal differentiation
These data suggest that Hoxa2 can repress neurogenesis in
pluripotent cell populations, but they also raise the question of
how the neural crest cells that arise from rhombomere 6, that
also express Hoxa2, are able to form neurons of the proximal
(superior) ganglion of the ninth cranial nerve. One difference
between r4- and r6-derived neural crest cells is that r6-derived
cells also express Hox3 paralogues (Manley and Capecchi,
1997), while r4-derived cells do not. To test the possibility that
Hox3 paralogues relieve the inhibition of neurogenesis caused
by Hoxa2, we examined neuronal differentiation in P19 cells
cotransfected with Hoxa2 and Hoxd3. In the presence of Pbx
and Meis, significantly higher rates of neurogenesis were ob-
served in cultures cotransfected with Hoxa2 and Hoxd3 relative
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Transfection of Hoxd3 and the cofactors, without Hoxa2, also
resulted in a consistent elevation of neurogenesis over that seen
in GFP control transfection (pb0.05), and this increase required
the cofactors. These results suggest that Hox3 paralogues
antagonize the inhibition of neurogenesis caused by Hoxa2 in a
manner consistent with the principle of posterior prevalence in
Hox gene function (Gonzalez-Reyes and Morata, 1990).
Hoxa2-mediated inhibition of neurogenesis in vivo
To determine if the inhibition of neurogenesis observed in
transfected P19 cells was relevant to the differentiation of neural
crest cells within intact embryos, we used electroporation in
chick embryos to force the expression of various combinations
of Hoxa2, Pbx1, and Meis1 in neural crest precursors that
normally generate both neurons and glia in the trigeminal gang-
lion. Neural crest cells that migrate to the trigeminal ganglion are
derived from the midbrain and r1 and r2 of the hindbrain, and do
not express any Hox gene. Although Hoxa2 is expressed within
the r2 neural tube, its expression is extinguished in the neural
crest cells that emerge from r2 [Prince and Lumsden, 1994Fig. 8. Neuronal differentiation of neural crest cells in the trigeminal ganglia after in v
top, dorsal at left) under conventional (A) or fluorescence (B) illumination. In panel
ventrical (VI) and in the trigeminal ganglion (gV). (mb: midbrain). (C) Coronal sectio
stage 10 with expression plasmids for GFP, Hoxa2, Pbx1, and Meis1, that was stained
three GFP-positive neurons with Islet1/2-positive nuclei (arrowheads); the inset at
Quantification of neuronal differentiation showing the percentage of GFP-positive
indicated expression plasmids. GFP-positive cells in the trigeminal ganglia of embryo
than those in embryos electroporated with either GFP alone or with Hox2/PBX1 (*#1285]. We electroporated mixtures of plasmids encoding GFP
and Hoxa2, with or without the Pbx1 and Meis1. The
electroporations were targeted to the midbrain–hindbrain
junction of HH stage 10 embryos (Hamburger Hamilton,
1952), just before the late-migrating NCCs that contribute to
the trigeminal ganglia emerge from the neural tube. This avoided
significant levels of plasmid expression in the crest-derived
ectomesenchyme of the first branchial arch, as occurs after
slightly earlier electroporations (Creuzet et al., 2002), and did
not generate notable alterations in the organization of craniofa-
cial tissues at the time of harvest (stages 27–28).
In control embryos electroporated with a GFP expression
plasmid, approximately 70% of the GFP-expressing cells in the
trigeminal ganglia also expressed Islet1/2, identifying them as
neurons (Fig. 8). By contrast, when Hoxa2 and both the Pbx1,
and Meis1 cofactors were expressed simultaneously, the fre-
quency of neuron differentiation was significantly reduced, to
approximately 40% (pb0.01). The frequency of neuronal
differentiation in a second set of control embryos, electro-
porated with a plasmid mix that contained Hoxa2 and Pbx1
expression vectors, but omitted the Meis1 vector, did not differ
from the GFP-only controls. Thus, the forced expression ofivo electroporation. (A, B) Lateral views of an electroporated embryo (rostral at
B, GFP expression is visible in the in the hindbrain (hb) adjacent to the fourth
n through the trigeminal ganglion of a stage 27 embryo that was electroporated at
with antibodies to GFP (green) and Islet 1/2 (red). The inset at lower right shows
upper left shows two cells whose nuclei did not express Islet1/2 (arrows). (D)
cell bodies that contained Islet1/2-positive nuclei after electroporation with the
s transfected with Hoxa2/Pbx1/Meis1 were less likely to differentiate as neurons
*pb0.01).
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reduces the frequency of neuronal differentiation by precursors
of the trigeminal ganglion.
Discussion
Control of peripheral neurogenesis by Hoxa2
A combination of lineage analyses of Hoxa2 mutant mouse
embryos, overexpression experiments in P19 cells, and mis-
expression studies in chick embryos has shown that the activity
of Hox genes can influence neurogenesis by cranial neural crest
cells and pluripotent embryonal carcinoma cells. We found that
the facial ganglia of Hoxa2 mutant embryos contained a
population of neurons derived from neural crest cells that was
not present in wild-type embryos. The generation of these neu-
rons occurred despite the presence of a grossly normal popu-
lation of placode-derived neurons. The phenotype suggests that
Hoxa2 expression in r4-derived neural crest cells normally
inhibits their ability to differentiate into sensory neurons, and
that this inhibition is relieved in the mutants. Additional data
consistent with this hypothesis were obtained in transfections of
P19 cells, in which Hoxa2 overexpression caused a reduction in
neuronal differentiation, and in experiments in which forcing
the expression of Hoxa2 in cells that populate the trigeminal
ganglion reduced the probability of neuronal differentiation. In
both P19 cells and chick embryos, the reduction of neurogenesis
required the presence of Pbx and Meis cofactors. In P19 cells,
Hoxa2-mediated inhibition of neurogenesis was abolished by
mutation of the Hox protein domain required for dimerization of
Hox and Pbx proteins, and could be antagonized by a member
of the Hox3 paralogous group.
In mouse embryos, the absence of Hoxa2 expression clearly
affected the generation of facial ganglion sensory neurons by r4-
derived neural crest cells, but did not appear to alter the
generation of parasympathetic neurons of the ptergopalatine
ganglion by the same crest population. The signaling cascades
that control sensory and parasympathetic neuron differentiation
are distinct from one another. The apparently normal generation
of r4-derived parasympathetic neurons in the ptergopalatine
ganglion suggests that Hoxa2 does not influence the signaling
pathways, including Mash1 and Phox2a among other factors,
that regulate parasympathetic neurogenesis (Hirsch et al., 1998;
Lo et al., 1998; Morin et al., 1997). By contrast, the appearance
of crest-derived sensory neurons in the facial ganglia of the
mutants was accompanied by a striking upregulation ofNeurog1
expression, and increases in Notch1 and Dl1 expression as well.
Neurog1 is required for the generation of sensory neurons by
cranial neural crest cells (Ma et al., 1999), and in a number of
systems, Neurog1 overexpression, by itself, is sufficient to
induce ectopic neurogenesis (Ma et al., 1996). In transfections of
P19 cells, we found that Hoxa2 expression could not antagonize
neurogenesis promoted by forced Neurog1 overexpression. This
result does not address the question of whether Hoxa2 normally
represses, directly or indirectly, the expression of the endogen-
ous mouse Neurog1 locus in vivo. It does, however, suggest that
Hoxa2 cannot significantly inhibit neurogenic mechanisms thatare initiated by Neurog1 expression. Our results are most
consistent with the idea that Hoxa2 acts upstream of Neurog1 in
neural crest cells to inhibit neurogenesis, and that the mutant
phenotype reflects a loss of this inhibition.
The generation of neurons by r4-derived neural crest cells in
Hoxa2 mutant embryos is unlikely to substantially alter the
generation of glial cells by the same lineage. Cranial neural crest
cell populations are capable of remarkable levels of regulative
migration, proliferation, and differentiation, including the com-
plete reconstitution of neuronal and glial populations of cranial
ganglia following surgical manipulations (Couly et al., 1996).
Additionally, the survival and proliferation of glial cell
precursors are regulated by factors in the local environment,
including many that are produced by differentiating neurons
(Anderson, 1997; Dong et al., 1995; Wakamatsu et al., 2000).
We therefore speculate that the generation of crest-derived
neurons in the proximal portion of the facial ganglion of Hoxa2
mutant embryos is likely to result in a local increase in the
survival and/or proliferation of glial precursors within the same
r4-derived neural crest cell population. We think it is unlikely
that the generation of these neurons has any effect on the
proliferation or differentiation of the ectomesenchymal deriva-
tives of the r4 neural crest, which have migrated beyond the
ganglionic anlagen by the time the supernumerary crest-derived
neurons begin to differentiate.
Fidelity of lineage marking by the B1Cre allele
The labeling of peripheral neurons and glia by the combi-
nation of the B1Cre and R26R alleles appeared to be virtually
complete and highly selective. Neural crest cells populate the
branchial arches in a distal to proximal order (Serbedzija et al.,
1992), so the first cells to emerge from the hindbrain form distal
ectomesenchyme. Although there is only a narrow temporal
window between the onset of Hoxb1 expression (Frohman et
al., 1990) and the generation of neural crest (Nichols, 1986;
Serbedzija et al., 1992), we found that the most distal ectome-
senchyme in the second arch was labeled, indicating that the
marker was recombined in the earliest neural crest cells to
migrate out of r4. Cell populations known to arise from non-
crest lineages were not labeled, including the ectoderm, the
mesodermal core, and the vascular endothelium (Le Douarin,
1983). In addition to r4-derived neural crest, the second
branchial arch is thought to contain small contributions from
r3- and r5-derived crest (Lumsden et al., 1991; Sechrist et al.,
1993; Serbedzija et al., 1992). We did not observe recombina-
tion in r3, and only low levels of recombination in r5, and yet
we were unable to find more than a rare unlabeled ectome-
senchymal cell in the second arch. We did observe a small
population of unmarked glial cells in the facial ganglion in wild-
type embryos that could have been derived from r3 or r5 neural
crest cells. The small number of unlabeled cells in distal
portions of the second branchial arch suggests that r3- and r5-
derived cells do not proliferate extensively, that they do not
survive, or that they are restricted to the margins of the labeled
territories, where they would not be recognized as part of the
second arch in these preparations.
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mutant embryos was caused by the presence of the null, B1Cre
allele used to mark the r4-derived lineages. Supernumerary,
TrkA-positive neurons were present in the ganglia of Hoxa2-
mutant embryos that were wild-type at the Hoxb1 locus
(Hoxa2−/−:Hoxb1+/+), and, conversely, were absent in em-
bryos that lacked all Hoxb1 function and were wild-type at the
Hoxa2 locus (Hoxa2+/+:Hoxb1Cre/Hoxb1Cre). It is also
unlikely that the phenotype is due to alterations in the expres-
sion of adjacent Hoxa family members, similar to the alterations
shown for recombinant alleles of some other Hox genes (Aubin
et al., 1998; Barrow and Capecchi, 1996; Ren et al., 2002; Rijli
et al., 1994), because the expression of Hoxa1 and Hoxa3 is
reported to be unaltered in Hoxa2 mutant embryos (Gendron-
Maguire et al., 1993; Rijli et al., 1993).
The results reported here differ from those of an earlier report
that also described the fates of neural crest cells derived from
Hoxb1-expressing neuroepithelium (Arenkiel et al., 2003).
Both studies agree on the predominantly glial fates of second
arch cells in the facial ganglion. Whereas Arenkiel et al. (2003)
did not comment on the lineage of the ptergopalatine ganglion
in their report, here we found that the neurons of this ganglion
arose from second arch neural crest cells. Significantly, this
establishes that neither Hoxb1 nor Hoxa2 expression in the r4
neuroepithelium or in the neural crest derived from r4, by
themselves, preclude neurogenesis. Although both Hoxa2 and
Hoxb1 are expressed in the r4 neuroepithelium, we (Fig. 1F)
and others (Frohman et al., 1990; Murphy et al., 1989) have
found that Hoxb1 expression is extinguished as crest cells
emerge from r4, while Hoxa2 expression is maintained at high
levels in the same cells. The generation of facial ganglion
neurons by r4-derived crest in Hoxa2 mutants and the lack of
such neurogenesis in Hoxb1 mutants strongly argue that the
inhibition of sensory neuron fates within the facial ganglion
during normal embryogenesis is a consequence of Hoxa2, and
not Hoxb1, gene function.
We additionally found that r4-derived glial cells were asso-
ciated with both motor and sensory components of the facial
nerve. Although Arenkiel et al. (2003) did not illustrate the
finding, they reported that r4-derived crest associated exclu-
sively with motor components, and did not associate with
sensory axons. Here, r4-derived neural crest cells were present
in the most distal portions of the chorda tympani, associated
with sensory axons that innervate lingual taste buds. r4-derived
cells also formed the glia associated with the axons running
between the acoustic ganglion and the otic vesicle.
There are several possible explanations for this difference
between the reports. Cre may be more efficiently expressed
from the fusion allele used here because it would not require re-
initiation of translation from a bicistronic message, as would be
the case (Gorski and Jones, 1999) for the IRES-Cre cassette
used by Arenkiel et al. (2003). We favor this explanation
because Arenkiel et al. illustrated incomplete activation of
reporter expression in the motor neuron axons and glia of a
purely motor branch of the facial nerve, suggesting that marker
activation may be incomplete elsewhere as well. Alternatively,
it could also be argued that we see labeling of glia associatedwith sensory axons because the B1Cre allele ectopically acti-
vated the reporter in cells that do not normally express Hoxb1.
Given that the timing and distribution of Cre expression
duplicated that of Hoxb1, and that reporter expression closely
resembled the cumulative pattern of Hoxb1 expression, we feel
this explanation is unlikely. Finally, it is possible that the differ-
ence between the sets of findings is due to unrecognized differ-
ences in genetic background among the mouse strains used,
though we again think this is not likely to be the explanation.
Site of Hoxa2 gene action
The repression of sensory neurogenesis in the facial ganglion
of wild-type embryos could result from a cell autonomous
activity of Hoxa2, or from cell–cell interactions between crest
cells in the ganglionic anlagen and those forming the ectome-
senchyme of the second arch, which also express Hoxa2. Both
the pattern of Hoxa2 expression in wild-type embryos and our
P19 cell transfections suggest that the inhibition is mediated by
cell autonomous mechanisms. In mutant embryos, neurogenesis
by crest cells began between E10.5 and E11.5. In wild-type
embryos, the mesenchymal cells expressing high levels of
Hoxa2 mRNA had migrated past the facial ganglion by E9.5,
and the mesenchymal cells surrounding the ganglion did not
express Hoxa2 mRNA. In contrast, high levels of Hoxa2
mRNA were observed in cells within the proximal nerve root,
the region where crest-derived neurons first appeared in mutant
embryos. Thus, in wild-type embryos, Hoxa2 was expressed in
the population of cells that generated the supernumerary neu-
rons in the mutants, and was not expressed at appreciable levels
in surrounding tissues.
The argument that Hoxa2 acts in a cell autonomous manner
to repress neurogenesis was strengthened by experiments in
which Hoxa2, Pbx1, and Meis1 were over-expressed in P19
cells and first brachial arch neural crest cells in chick embryos.
In both cases, the misexpression led to reproducible reductions
in the frequency of neuronal differentiation. In P19 cells, the
frequency of neuronal differentiation in a test population was
not influenced by expression of Hoxa2, Pbx1 and Meis1 in
feeder cell layers. In the chick embryo electroporations, the
GFP-expressing cells were dispersed throughout the trigeminal
ganglia, making it unlikely that the transfected cells expressing
Hoxa2 affected one another through cell interactions. Collec-
tively, these experiments suggest that the reduction of neuronal
differentiation in P19 cells, the reduction in trigeminal
neurogenesis in electroporated chick embryos, and the small
number of crest-derived neurons present in the facial ganglia of
wild-type embryos are each due to a cell autonomous activity of
Hoxa2.
The transfection data also add to accumulating evidence
(Knoepfler and Kamps, 1997) that the Pbx and Meis proteins,
probably through their interactions with Hox proteins, are key
players in the control of neuronal differentiation in P19 cells
(Knoepfler and Kamps, 1997; Qin et al., 2004a,b). It has long
been recognized that the induction of neuronal differentiation
by retinoic acid in embryonal carcinoma cells, including P19
cells, is associated with increased expression of multiple Hox
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retinoic acid also leads to increases in the levels of Pbx andMeis
proteins (Knoepfler and Kamps, 1997; Qin et al., 2004a), and
that reducing Pbx protein levels, through the use of antisense or
short interfering RNA’s, reduces neuronal differentiation in
retinoic acid treated P19 cells (Qin et al., 2004b).
Pbx and Meis proteins are TALE (three amino acid loop
extension) homeodomain transcription factors that modulate the
activity of many members of the Hox gene family (Moens and
Selleri, 2006). The association of Hox and Pbx proteins in
DNA-bound complexes requires a pentapeptide sequence (F/
YPWMR/K) amino-terminal to the homeodomain of the Hox
partner (Knoepfler et al., 1999). The cooperative binding of Hox
and Pbx proteins alters the binding affinity and specificity of the
Hox partner, and typically increases transcription of target
genes, although more complex interactions that depend on cell-
ular context have also been reported (Saleh et al., 2000). We are
not aware of prior reports describing alterations in the frequency
of neuronal differentiation of P19 cells that are caused by
misexpression of Hox family members. Here, we found that P19
cells overexpressing Hoxa2 or Hoxd3 exhibited reproducible
changes in the frequency of neurogenesis, that these changes
were only observed in the presence of the Pbx and Meis co-
factors, and that the Hoxa2-mediated inhibition was not
observed when the critical tryptophan residue of the peptide
(F/YPWMR/K) required for interaction with Pbx proteins
(Knoepfler and Kamps, 1995) was mutated.
Hox genes and peripheral neurogenesis
We suggest that phenotype of the facial ganglion in Hoxa2
mutant embryos represents an anterior transformation of the
developmental potential of a set of cranial neural crest cells,
similar to that seen in mesenchymal tissues of Hoxa2 mutants
(Gendron-Maguire et al., 1993; Rijli et al., 1993), and in a
variety of skeletal and CNS tissues of animals lacking various
single Hox gene functions (Duboule and Morata, 1994;
Gonzalez-Reyes et al., 1990). The transformation appears to
be limited to the generation of ectopic neurons, and does not
extend to the formation of connections between these neurons
and the targets normally innervated by trigeminal ganglion
neurons (data not shown). Differences in the terminal fates of
neural crest cells generated at different levels of the body axis,
and in particular the differentiation of sensory and autonomic
neurons, are strongly influenced by the tissues through which
crest cells migrate and in which they settle (Baker et al., 1997;
Le Douarin and Smith, 1988). This applies to the generation of
neuronal and non-neuronal cells by cranial neural crest cells as
well. For example, the normally gliogenic crest cells of the
nodose ganglion form neurons when they are transplanted to the
trunk (Ayer-LeLievre and LeDouarin, 1982). Additionally, the
removal of placode-derived neurons through surgical ablation
(Harrison et al., 1995) or by genetic means (Fode et al., 1998)
can induce neural crest cells that normally do not form neurons
to generate large numbers of neurons.
An exception to the dominant role of surrounding tissues in
the determination of neural crest cell fates is the control ofectomesenchymal fates of first and second branchial arch
neural crest cells by Hox gene function. Transplantation of the
Hox-negative frontonasal, mesencephalic, or metencephalic
neural folds into more posterior levels results in the ectopic
formation of bones of the lower jaw (Noden, 1983), which
likely results from the repression of Hoxa2 expression by FGF8
signaling from the transplanted tissue (Trainor et al., 2002).
Conversely, Hox-expressing neural crest cells from the
hindbrain do not form appropriate facial skeletal elements
when transplanted into the first branchial arch domain (Couly
et al., 1998), and the misexpression of Hox genes in first
branchial arch neural crest cells also prevents the formation of
facial skeletal structures normally derived from these cells
(Creuzet et al., 2002).
In these paradigms, a key feature of the transposed crest cell
populations is the presence or absence of the expression of any
of several Hox genes. By contrast, the repression of neurogen-
esis reported here is likely to be specific toHoxa2, as Hox genes
are expressed in other cranial crest cell populations that do
generate neurons. The idea that Hoxa2 function represses
neurogenesis may explain phenotypic attributes of embryos
with reduced Hox3 paralogous group function. In embryos
lacking function of any two Hox3 group genes, neurons of the
proximal portion of the ninth cranial ganglion, normally derived
from neural crest cells that arise from the posterior hindbrain,
are often missing (Manley and Capecchi, 1997). As both Hoxa2
and members of the Hox3 paralogous group are expressed in
these neural crest cells, it is possible that, in the absence of
sufficient Hox3 function, the normally inapparent inhibition of
neurogenesis by Hoxa2 becomes apparent. Our observation
that the inhibition of neurogenesis by Hoxa2 was antagonized
by the simultaneous expression of Hoxd3 in P19 cell cultures
is consistent with this mechanism. Both the mutant pheno-
types and the results of the P19 cell transfections are also
consistent with the posterior prevalence of Hox gene functions
(Duboule, 1991; Gonzalez-Reyes and Morata, 1990). By this
argument, Hoxa2 activity in second branchial neural crest
cells arch suppresses the capacity for neurogenesis shown by
the Hox-negative first branchial arch neural crest, and the
function of Hox paralogous group 3 gene in the third
branchial arch antagonizes this repression of neurogenesis
by Hoxa2.
Two stages of neurogenesis
Biphasic patterns of neurogenesis occur in sensory ganglia at
all levels of the neuraxis. Placode-derived neurons are born
before crest-derived neurons in cranial ganglia (Altman and
Bayer, 1982; d’Amico-Martel and Noden, 1980). In spinal
dorsal root ganglia, Neurog2-dependent neurons arise before
Neurog1-dependent neurons (Ma et al., 1999). Furthermore,
the two phases are largely independent of one another. Placode-
derived neurons of the seventh, ninth, and tenth ganglia are
generated in the absence of Neurog1 function, as are the
Neurog2-dependent neurons of spinal dorsal root ganglia (Ma
et al., 1998, 1999). Loss of Neurog2 function leads to a slight
delay in the onset of Neurog1-dependent neurogenesis in spinal
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eventually form substantial populations (Ma et al., 1999).
In Hoxa2 mutant embryos, crest-derived neurons arose after
placode-derived neurons had assembled in the ganglionic
anlagen. The onset of crest-derived neurogenesis may mark
the point at which second brachial arch crest cells become
competent to differentiate as neurons. This would be consistent
with the timing of neurogenesis, presumably by neural crest, in
the facial ganglia of Neurog2 mutant embryos (Fode et al.,
1998). Placode-derived facial ganglion neurons are not
generated in these embryos, there are no neurons present at
E10.5, but a substantial population is present at E12.5. If the
initial failure of crest to generate neurons represents an active
repression of neurogenic potential, then the timing of
neurogenesis in these two mutants suggests that this early
repression is independent of the presence of placode-derived
neurons, which are present in the Hoxa2 mutants, or Hoxa2
function, which is present in the Neurog2 mutants. Alterna-
tively, if it represents a delayed acquisition of neurogenic
potential, then this potential is normally subject to further
inhibition by Hoxa2, and this inhibition can be overridden by
the absence of placode-derived neurons.
Conclusion
A large body of experimentation has established that neural
crest cells are endowed with broad developmental potential (Le
Douarin, 1983), that their differentiation is strongly influenced
by signals generated by surrounding tissues, and that under
appropriate conditions even fates traditionally considered
incompatible with one another can be adopted (McGonnell
and Graham, 2002). Nonetheless, in the intact embryo, parti-
cular subsets of the potential fates are adopted by cohorts of
neural crest cells that arise at specific times and at particular
axial levels. Although Hox gene expression is a major deter-
minant of axial patterning in the embryo, differences in
peripheral neurogenic fates of neural crest cells have not
typically been associated with temporal or spatial differences in
Hox gene activity. The results presented here suggest that a
closer examination of the relationship between Hox gene ex-
pression and the neuronal fates of neural crest cells is warranted.
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